Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
April 29, 2014
Patent Application Number
10135975
Date Filed
April 30, 2002
Patent Primary Examiner
Patent abstract
Provided are pharmaceutical drugs for preventing or mitigating adverse actions associated with taxane antineoplastic drugs which are frequently and widely used in cancer chemotherapy, and pharmaceutical compositions which allow us to shorten the duration of treatment with taxane antineoplastic agents and/or to repeat the taxane treatment course more times, as well as drugs suitable for the therapeutic schedules.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
